Moore Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 400 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 426 |
|
|
2023
Q2 | – | Sell |
-75,000
| Closed | -$4.95M | – | 473 |
|
|
2023
Q1 | $4.95M | Buy |
75,000
+65,000
| +650% | +$4.29M | 0.1% | 138 |
|
|
2022
Q4 | $517K | Sell |
10,000
-169,958
| -94% | -$8.79M | 0.01% | 334 |
|
|
2022
Q3 | $12.3M | Buy |
+179,958
| New | +$12.3M | 0.29% | 47 |
|
|
2019
Q2 | – | Sell |
-50,527
| Closed | -$985K | – | 292 |
|
|
2019
Q1 | $985K | Buy |
+50,527
| New | +$985K | 0.03% | 225 |
|